The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Altered glutathione redox state in schizophrenia.
Open accessAbstract
Altered antioxidant status has been reported in schizophrenia. The glutathione (GSH) redox system is important for reducing oxidative stress. GSH, a radical scavenger, is converted to oxidized glutathione (GSSG) through glutathione peroxidase (GPx), and converted back to GSH by glutathione reductase (GR). Measurements of GSH, GSSG and its related enzymatic reactions are thus important for evaluating the redox and antioxidant status. In the present study, levels of GSH, GSSG, GPx and GR were assessed in the caudate region of postmortem brains from schizophrenic patients and control subjects (with and without other psychiatric disorders). Significantly lower levels of GSH, GPx, and GR were found in schizophrenic group than in control groups without any psychiatric disorders. Concomitantly, a decreased GSH:GSSG ratio was also found in schizophrenic group. Moreover, both GSSG and GR levels were significantly and inversely correlated to age of schizophrenic patients, but not control subjects. No significant differences were found in any GSH redox measures between control subjects and individuals with other types of psychiatric disorders. There were, however, positive correlations between GSH and GPx, GSH and GR, as well as GPx and GR levels in control subjects without psychiatric disorders. These positive correlations suggest a dynamic state is kept in check during the redox coupling under normal conditions. By contrast, lack of such correlations in schizophrenia point to a disturbance of redox coupling mechanisms in the antioxidant defense system, possibly resulting from a decreased level of GSH as well as age‐related decreases of GSSG and GR activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Redox dysregulation has been observed in schizophrenic patients, who have defective antioxidant systems and exhibit increased lipid peroxidation (Do et al., 2000; Yao et al., 2006; Flatow et al., 2013).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Yao et al., 2006
In the citing paper
“Higher levels of oxidative stress have been reported in schizophrenia (Wang et al, 2009;Yao et al, 2006)”
From Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia (2016) · cites this paper as Yao et al, 2006
In the citing paper
“In an animal model with low GSH content, as reported in the brain of some schizophrenia patients (Do et al., 2000; Gawryluk et al., 2011; Yao et al., 2006), there is a deficit in prefrontal and hippocampal PVI, impairing high-frequency neuronal synchronization (Cabungcal et al., 2013a; Cabungcal et al., 2013b; Steullet et al., 2010).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Yao et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Free-Radical Chemistry of Cigarette Smoke and Its Toxicological Implications
CHURCH, D. F., & PRYOR, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,442
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267 · cited 1×
“Its reducing and nucleophilic properties protect cells against destructive effects of reactive oxygen species and free radicals [12].”
Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea
Pryor, W. A., & Stone, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,179
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Glutathione: an overview of biosynthesis and modulation
Anderson, M. E. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00146-4 · Cited by 917
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Forman, H. J., Fukuto, J. M., & Torrès, M. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00516.2003 · Cited by 533
Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease
Rahman, I., & MacNee, W. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.6.l1067 · Cited by 420
Kinetics of Nitrosation of Thiols by Nitric Oxide in the Presence of Oxygen
Kharitonov, V. G., Sundquist, A. R., & Sharma, V. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28158 · Cited by 365
Cited by
Sorted by citations
Items 201–300 of 320
Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices
Herrmann, A. P., Lunardi, P. S., Pilz, L. K., Tramontina, A. C., Linck, V. M., Okunji, C. O., Gonçalves, C. A., & Elisabetsky, E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.006 · Cited by 21
Fine‐mapping reveals novel alternative splicing of the dopamine transporter
Talkowski, M. E., McCann, K. L., Chen, M., McClain, L. L., Bamne, M. N., Wood, J. A., Chowdari, K. V., Watson, A. M. M., Prasad, K. M. R., Kirov, G., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31125 · Cited by 20
Self-citationOxidative Stress and the Metabolic Pathology of Autism
James, S. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-489-0_11 · Cited by 20
Placebo-Controlled Augmentation Trials of the Antioxidant Nac in Schizophrenia: A Review
Chen, A. T., Chibnall, J. T., & Nasrallah, H. A. (2016) · Annals of Clinical Psychiatry · doi:10.1177/104012371602800308 · Cited by 20
Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms
Ünal, K., Erzın, G., Yüksel, R. N., Alışık, M., & Erel, Ö. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1441906 · Cited by 20
Rogóż, Z., Kamińska, K., Lech, M. A., & Lorenc‐Koci, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042125 · Cited by 21
Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?
Seybolt, S. E. J. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.034 · Cited by 19
Pejovic-Milovancevic, M. M., Mandić-Maravić, V., Coric, V. M., Mitković-Vončina, M., Kostic, M. V., Savic-Radojevic, A. R., Ercegovac, M., Matic, M. G., Peljto, A., Lečić‐Toševski, D., et al. (2016) · Laboratory Medicine · doi:10.1093/labmed/lmw017 · Cited by 20
Marković, B., Radonjić, N. V., Jevtić, G., Stojković, T., Velimirović, M., Aksić, M., Poleksić, J., Nikolić, T., Aleksić, D., Radonjić, V., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7390516 · Cited by 20
Schmidt, S. J., Hurlemann, R., Schultz, J., Wasserthal, S., Kloss, C., Maier, W., Meyer‐Lindenberg, A., Hellmich, M., Muthesius, A., Pantel, T., et al. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12781 · Cited by 19
Ansarey, S. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.771144 · Cited by 21
Beeraka, N. M., Ávila-Rodriguez, M., & Aliev, G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02703-4 · Cited by 18
Li, S., Luo, X., Liao, Z., Xu, H., Liang, M., Mai, K., & Zhang, Y. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.09.015 · Cited by 19
Lech, M. A., Leśkiewicz, M., Kamińska, K., Rogóż, Z., & Lorenc‐Koci, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126171 · Cited by 20
Jeon, P., Limongi, R., Ford, S. D., Branco, C., Mackinley, M., Gupta, M., Powe, L., Théberge, J., & Palaniyappan, L. (2020) · medRxiv · doi:10.3390/brainsci11070941 · Cited by 16
N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A preliminary MRS study
Yang, Y. S., Maddock, R. J., Zhang, H., Lee, J., Hellemann, G., Marder, S. R., & Green, M. F. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111515 · Cited by 17
Schizophrenia and Glutathione: A Challenging Story
Carletti, B., Banaj, N., Piras, F., & Bossù, P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111526 · Cited by 17
Autism: A Systems Biology Disease
Randolph-Gips, M. M. (2011) · IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology · doi:10.1109/hisb.2011.13 · Cited by 17
Protective effect of N-acetylcysteine on MK-801-induced testicular oxidative stress in mice
Türkmen, R., AKOSMAN, M. S., & Demirel, H. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.139 · Cited by 17
Raffa, M., Lakhdar, R., Ghachem, M., Barhoumi, S., Safar, M. T., Jrad, B. B. H., Khelil, A. H., Kerkeni, A., & Mechri, A. (2012) · Gene · doi:10.1016/j.gene.2012.10.031 · Cited by 17
Artiukhov, A. V., Graf, A. V., Kazantsev, A. V., Boyko, A. I., Aleshin, V. A., Ksenofontov, A. L., & Bunik, V. I. (2022) · Pharmaceuticals · doi:10.3390/ph15020182 · Cited by 16
Rarinca, V., Vasile, A., Visternicu, M., Burlui, V., Halitchi, G., Ciobica, A. S., Sîngeap, A.-M., Dobrin, R., Burlui, E., Maftei, L., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1497569 · Cited by 19
Dean, O. M., Bush, A. I., Berk, M., Copolov, D., & van den Buuse, M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.08.013 · Cited by 16
Prokhorova, T. A., Терешкина, Е. Б., Savushkina, O. K., Бокша, И. С., Vorobyeva, E. A., Omelchenko, M. A., Николаевич, П. А., Каледа, В. Г., & Burbaeva, G. S. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911904147 · Cited by 16
The Association between Cataract Surgery and Atypical Antipsychotic Use: A Nested Case-Control Study
Pakzad-Vaezi, K. L., Etminan, M., & Mikelberg, F. S. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.07.012 · Cited by 15
Zhang, K., Zou, L., & Cai, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1505397 · Cited by 16
Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
Trubalski, M., Markiewicz-Gospodarek, A., Żerebiec, M., Poleszak, J., Szczotka, M., Markiewicz, R., Łoza, B., & Szymańczyk, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211139 · Cited by 17
No association between glutathione‐synthesis‐related genes and Japanese schizophrenia
Hanzawa, R., Ohnuma, T., Nagai, Y., Shibata, N., Maeshima, H., Baba, H., Hatano, T., Takebayashi, Y., Hotta, Y., Kitazawa, M., et al. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02157.x · Cited by 14
Reyes-Madrigal, F., León-Ortíz, P., Mao, X., Mora-Durán, R., Shungu, D. C., & de la Fuente‐Sandoval, C. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.003 · Cited by 14
Oxidative biology: new intervention opportunities in psychiatry
Berk, M. (2007) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2007.00224.x · Cited by 14
Butticaz, C., Werge, T. M., Beckmann, J. S., Cuénod, M., Kim, Q., & Rivolta, C. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32832cef21 · Cited by 14
Cecerska‐Heryć, E., Polikowska, A., Serwin, N. M., Michalczyk, A., Stodolak, P., Goszka, M., Zoń, M., Budkowska, M., Tyburski, E. M., Podwalski, P., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.05.018 · Cited by 13
Schizophrenia and oxidative stress from the perspective of bibliometric analysis
Chen, M.-Y., Zhang, Q., Liu, Y., Zheng, W.-Y., Si, T. L., Su, Z., Cheung, T. C. C., Jackson, T., Li, X., & Xiang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1145409 · Cited by 13
Kim, Q., Conus, P., & Cuénod, M. (2010) · Lifestyle Genomics · doi:10.1159/000324366 · Cited by 13
The antidepressant effect of bone marrow mononuclear cell transplantation in chronic stress
do Prado‐Lima, P. A. S., Onsten, G. A., de Oliveira, G. N., Brito, G. C., Ghilardi, I. M., de Souza, E. V., dos Santos, P. G., Salamoni, S. D., Machado, D. C., Duarte, M. M. M. F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119841562 · Cited by 12
Oxidative Stress in the Early Stage of Psychosis
Ventriglio, A., Bellomo, A., Favale, D., Bonfitto, I., Vitrani, G., Dario, D. S., Cuozzo, E., Ilaria, D. G., Pettorruso, M., Perna, G., et al. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210701105839 · Cited by 12
Kędracka–Krok, S., Świderska, B., Jankowska, U., Skupień-Rabian, B., Solich, J., & Dziedzicka‐Wasylewska, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.028 · Cited by 10
Fisher, E., Gillam, J., Upthegrove, R., Aldred, S., & Wood, S. J. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12833 · Cited by 10
Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs
Doğan, H. O., Erşan, E. E., Aydın, H., Erdoğan, S., Erşan, S., Alışık, M., Bakır, S., Erel, Ö., & Koç, D. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.39 · Cited by 11
Ricci, V., Martinotti, G., Mosca, A., & Maina, G. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1740079 · Cited by 11
Role of Redox Dysregulation in White Matter Anomalies Associated with Schizophrenia
Monin, A., Fournier, M., Baumann, P., Cuénod, M., & Kim, Q. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00028-6 · Cited by 10
Korkmaz, Ş. A., Kaymak, S. U., Neşeli̇oğlu, S., & Erel, Ö. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1084 · Cited by 9
Bové, M., Morgese, M. G., Dimonte, S., Sikora, V., Agosti, L. P., Palmieri, M. A., Tucci, P., Schiavone, S., & Trabace, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110945 · Cited by 9
Oxidative Stress in Psychiatric Disorders
Fung, L. K., & Hardan, A. Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-5311-5_4 · Cited by 9
Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products
Sahi, A. K., Verma, P., Varshney, N., Gundu, S., & Mahto, S. K. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-03860-5 · Cited by 10
A Potential Biomarker for Predicting Schizophrenia: Metallothionein-1
Yılmaz, S. A., Kılıç, N., Kaya, Ş., & Taşçı, G. (2023) · Biomedicines · doi:10.3390/biomedicines11020590 · Cited by 9
Role of Oxidative Stress in Pathophysiological Progression of Schizophrenia
Bhatt, S., Upadhyay, T., Patil, C., Pai, K. S. R., Chellappan, D. K., & Dua, K. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220822154558 · Cited by 8
Wszelaki, N., & Melzig, M. F. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.04.007 · Cited by 8
Озорнина, Н. В., Озорнин, А. С., & Говорин, Н. В. (2013) · Neurochemical Journal · doi:10.1134/s1819712413030112 · Cited by 8
Carbonyl stress in schizophrenia
Itokawa, M., Miyashita, M., Arai, M., & Miyata, T. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140044 · Cited by 8
Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
Kaddurah‐Daouk, R., Soares, J. C., & Quinones, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_6 · Cited by 9
Cengiz, M., Bayoglu, B., Alansal, N. O., Cengiz, S., Dirican, A., & Kocabasoglu, N. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1016973 · Cited by 7
Sasuclark, A. R., Watanabe, M., Roshto, K., Kilonzo, V. W., Zhang, Y., & Pitts, M. W. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103548 · Cited by 8
Brito, R. M. D. M., Meurer, Y. D. S. R., Batista, J. A. L., de Sá, A. L., Souza, C. R. D. M., de Souto, J. T., & de Andrade‐Neto, V. F. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05596-x · Cited by 7
Górny, M., Bilska-Wilkosz, A., Iciek, M., Rogóż, Z., & Lorenc-Koci, E. (2023) · The FEBS Journal · doi:10.1111/febs.16944 · Cited by 8
Oxidative Stress is a New Avenue for Treatment of Neuropsychiatric Disorders: Hype of Hope?
Negah, S. S., & Forouzanfar, F. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230904150907 · Cited by 7
Unstable genes unstable mind: Beyond the central dogma of molecular biology
Hegde, M. V., & Saraph, A. A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.051 · Cited by 7
Kyriakou, S., Cheung, W., Mantso, T., Mitsiogianni, M., Anestopoulos, I., Veuger, S. J., Trafalis, D. T. P., Franco, R., Pappa, A., Tétard, D., et al. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01087-5 · Cited by 7
Dysregulation of Glutathione Synthesis in Psychiatric Disorders
Lorenc‐Koci, E. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_14 · Cited by 7
Oxidative stress in schizophrenia as a promising target for psychopharmacotherapy
Потанин, С. С., & Ma, M. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2021121091131 · Cited by 6
Raffa, M., Jrad, B. B. H., Khelil, A. H., Kerkeni, A., & Mechri, A. (2016) · Gene Reports · doi:10.1016/j.genrep.2016.07.007 · Cited by 6
Neurobiology of Schizophrenia Spectrum Disorders
Heckers, S. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n5p431 · Cited by 6
Li, Y., Lei, K., Xu, X., Rajput, I. R., DongYou, Y., & WeiFen, L. (2013) · International Journal of Agriculture and Biology · Cited by 5
Manzoor, S., Ayesha, K., Hasan, B., Mushtaq, S., & Ahmed, N. (2021) · Current Proteomics · doi:10.2174/1570164618666210121151004 · Cited by 5
Oxidative Stress in Schizophrenia
Dietrich‐Muszalska, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_2 · Cited by 5
Therapeutic possibilities of cysteamine in the treatment of schizophrenia
Pae, C., Lee, C., & Paik, I. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.045 · Cited by 5
Chen, M. X., Cheng, S. H., Lei, L., Zhang, X. F., Liu, Q., Lin, A., Wallis, C. U., Lukowicz, M. J., Sham, P. C., Li, Q., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105041 · Cited by 7
Lavoie, S., Steullet, P., Kulak, A., Preitner, F., Kim, Q., & Magistretti, P. J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00142 · Cited by 5
Savushkina, O. K., Бокша, И. С., Prokhorova, T. A., Терешкина, Е. Б., Burminskiy, D. S., Ma, M., Vorobyeva, E. A., & Burbaeva, G. S. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811811177 · Cited by 5
Tavitian, A., Lax, E., Song, W., Szyf, M., & Schipper, H. M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119899 · Cited by 4
Oxidative Stress in Depression and Other Comorbid Disorders
Bhatt, S., Pandey, D. K., Patil, C. R., & Nagappa, A. N. (2020) · Springer eBooks · doi:10.1007/978-981-15-1568-2_9 · Cited by 5
de Lima, E. E., Castro, L. S. E. P. W., Grinevicius, V. M. A. S., Hilbig, J., Mota, N. S. R. S., Zeferino, R. C., da Silva, R. C., Jachmanián, I., da Silva, E. L., Pedrosa, R. C., et al. (2020) · Food and Nutrition Sciences · doi:10.4236/fns.2020.1111073 · Cited by 4
Glutathione Deficit and Redox Dysregulation in Animal Models of Schizophrenia
Steullet, P., Cabungcal, J.-H., Kulak, A., Cuénod, M., Schenk, F., & Kim, Q. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_7 · Cited by 4
Kulak, A. (2012) · Schizophrenia Research · doi:10.1016/s0920-9964(12)70162-7 · Cited by 4
Pavan, T., Steullet, P., Alemán‐Gómez, Y., Jenni, R., Schilliger, Z., Cleusix, M., Alameda, L., Kim, Q., Conus, P., Hagmann, P., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103883 · Cited by 3
Savushkina, O. K., Бокша, И. С., Терешкина, Е. Б., Prokhorova, T. A., Sheshenin, V., Витальевна, П. В., Vorobyeva, E. A., & Burbaeva, G. S. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-4-41-50 · Cited by 3
Selenium-Functionalized Molecules (SeFMs) as Potential Drugs and Nutritional Supplements
Abdur, R., & Huang, Z. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_87 · Cited by 3
Suppressive Effects of Puerariae Radix on the Breast Tumor Incidence in Rats Treated with DMBA
Chen, C., Wu, S., Tseng, Y.-M., Liao, J.-B., Fu, H.-T., Tsai, S., & Tsai, L. (2017) · Journal of Agricultural Science · doi:10.5539/jas.v9n7p68 · Cited by 3
Papel del estrés oxidativo en la esquizofrenia
Soto‐Bernardini, M. C., & Raventós, H. (2008) · Acta Médica Costarricense · doi:10.51481/amc.v50i4.3 · Cited by 3
Ogunro, P. S., Eegunranti, B. A., Atiba, A. S., Oke, E. O., & Akande, J. O. (2013) · Free Radicals and Antioxidants · doi:10.1016/j.fra.2013.03.005 · Cited by 3
Schizophrenia, Oxidative Stress and Selenium
Pitts, M. W., Raman, A. V., & Berry, M. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1025-6_28 · Cited by 3
Crosstalk between Nitric Oxide and Bioinorganic Centers: Implications for Cellular Signaling
Oszajca, M., Polaczek, J., Rutkowska‐Zbik, D., Gurgul, I., Mazuryk, O., & Stochel, G. (2025) · The Chemical Record · doi:10.1002/tcr.202500128 · Cited by 2
Barzon, B., Marchiotto, F., Nasini, S., Casile, A., Peluso, S., Cifani, C., Pitsikas, N., Gobbi, G., Cambiaghi, M., & Comai, S. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117725 · Cited by 2
Glucose-6-phosphate dehydrogenase deficiency and psychotic disorders: A systematic review
Gandar, C., Scott, J. G., & Warren, N. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2290563 · Cited by 2
Schizophrenia: One Coat of Many Colors
Smythies, J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00043 · Cited by 2
Chen, N., Liu, H., Yao, J., Chen, S., Xiu, M., Wu, F., & Zhang, X. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103267 · Cited by 2
Self-citationRaffa, M., Youssef, I. B. H., Othman, L. B., Fendri, C., & Mechri, A. (2021) · L Encéphale · doi:10.1016/j.encep.2020.01.010 · Cited by 2
Savushkina, O. K., Бокша, И. С., Sheshenin, V., Терешкина, Е. Б., Prokhorova, T. A., Витальевна, П. В., Vorobyeva, E. A., & Burbaeva, G. S. (2021) · Neurology Bulletin · doi:10.17816/nb87427 · Cited by 2
Senapati, D. K., Yarava, J. R., Ramanathan, K. V., & Raghothama, S. (2024) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.5486 · Cited by 1
Rogóż, Z., Kamińska, K., & Wąsik, A. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174028 · Cited by 1
The role of 5-HT3 receptors in schizophrenia and associated depressive and addictive comorbidities
Jůza, R., Więckowska, A., Vojtěchová, I., Kuča, K., Soukup, O., Korábečný, J., & Petrásek, T. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111663 · Cited by 1
Wang, R., Li, Y., Shi, D., Huang, H., Ren, Z., Ge, Y., Chang, Y., & Yan, G. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104215 · Cited by 2
Oxidative stress, antioxidant defenses, and schizophrenia
Ong, W., Sim, K., & Farooqui, A. A. (2010) · Asia-Pacific Psychiatry · doi:10.1111/j.1758-5872.2010.00090.x · Cited by 1
Oxidative Stress and Neuropsychiatric Disorders in the Life Spectrum
Nunomura, A., Tamaoki, T., Motohashi, N., Lee, H., Zhu, X., & Perry, G. L. (2016) · CRC Press eBooks · doi:10.1201/b20228-16 · Cited by 1
Mayén-Lobo, Y. G., Alcaraz-Zubeldia, M., de Montellano, D. J. D., Motilla-Frías, B. A., García-Manteca, M. Y., Ortega‐Vázquez, A., Aviña-Cervantes, C. L., Crail‐Meléndez, D., Rı́os, C., López, M., et al. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2783 · Cited by 1
Lorenc‐Koci, E., Górny, M., Chwatko, G., Kamińska, K., Iciek, M., & Rogóż, Z. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00607-3 · Cited by 1
Burlui, E., Rarinca, V., Ciobica, A. S., Burlui, V., Dobrin, R., & Stadoleanu, C. (2025) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2025.1542913 · Cited by 2
Melatonin as a Biological Marker in Schizophrenia
Morera, A. M., Abreu-González, P., & Henry, M. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_8 · Cited by 1
Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 1
Metadata
- Authors
- Yao, J. K., Leonard, S., & Reddy, R.
- Affiliations
- University of Pittsburgh (US)
- Denver VA Medical Center (US)
- VA Pittsburgh Healthcare System (US)
- Corresponding author
- Yao, Jeffrey K.
- ORCID
- Reddy, Ravinder
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 22
- Issue
- 1-2
- Pages
- 83-93
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- PMC
- PMC3850558
- OpenAlex
- W2088215062
- Cited by
- 321
- References
- 45
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 20 · 2021: 20 · 2020: 10 · 2019: 16 · 2018: 19 · 2017: 18 · 2016: 18 · 2015: 21 · 2014: 12 · 2013: 18 · 2012: 21
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Disease Markers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH58141, MH64118, DA09457)
- Brain and Behavior Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- schizophrenia, glutathione, glutathione disulfide, glutathione peroxidase, glutathione reductase, GSH/GSSG ratio, oxidative stress, antioxidant defense, redox coupling, caudate nucleus, postmortem brain, age-related decline
- MeSH terms
- Age Factors, Aged, Caudate Nucleus, Female, Glutathione, Glutathione Reductase, Humans, Male, Middle Aged, Oxidation-Reduction, Schizophrenia, Sex Factors, Smoking, Glutathione Disulfide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
